LifeScience Biologics
PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. announced that they have entered into a drug discovery collaboration agreement (the "Collaborat...
March 16, 2026 | News
Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative du...
March 16, 2026 | News
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility...
March 13, 2026 | News
Collaboration aims to support development of a robust lentiviral production platform for gene therapy applications Merck’s VirusExpress™293T...
March 12, 2026 | News
Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developi...
March 12, 2026 | News
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
March 11, 2026 | News
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at adva...
March 11, 2026 | News
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology an...
March 10, 2026 | News
Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and AI-driven multimodal...
March 09, 2026 | News
Cytiva has expanded its Fast Trak process development and training facility in Bengaluru, reinforcing its commitment to supporting India’s rapidly ad...
March 09, 2026 | News
The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighti...
March 06, 2026 | News
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. Terumo Blood and Cell Technologies (Terumo BCT) annou...
March 06, 2026 | News
New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold...
March 06, 2026 | News
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, t...
March 05, 2026 | News
Most Read
Bio Jobs
News